참고문헌
- Akdeniz O, Akduman D, Haksever M, et al (2013). Relationships between clinical behavior of laryngeal squamous cell carcinomas and expression of VEGF, MMP-9 and E-cadherin. Asian Pac J Cancer Prev, 14, 5301-10. https://doi.org/10.7314/APJCP.2013.14.9.5301
- Andrews NA, Jones AS, Helliwell TR, et al (1997). Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer, 75, 1474-80. https://doi.org/10.1038/bjc.1997.252
- Ariyawardana A, Johnson NW (2013). Trends of lip, oral cavity and oropharyngeal cancers in Australia 1982-2008: overall good news but with rising rates in the oropharynx. BMC Cancer, 13, 333. https://doi.org/10.1186/1471-2407-13-333
- Bankfalvi A, Krassort M, Buchwalow IB, et al (2002). Gains and losses of adhesion molecules (CD44, E-cadherin, and betacatenin) during oral carcinogenesis and tumour progression. J Pathol, 198, 343-51. https://doi.org/10.1002/path.1204
- Beavon IR (2000). The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer, 36, 1607-20. https://doi.org/10.1016/S0959-8049(00)00158-1
- Bryne M, Koppang HS, Lilleng R, et al (1989). New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med, 18, 432-7. https://doi.org/10.1111/j.1600-0714.1989.tb01339.x
- Cai ZG, Shi XJ, Gao Y, et al (2008). beta-catenin expression pattern in primary oral squamous cell carcinoma. Chin Med J (Engl), 121, 1866-70.
- Chow V, Yuen AP, Lam KY, et al (2001). A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma. J Cancer Res Clin Oncol, 127, 59-63. https://doi.org/10.1007/s004320000177
- da Silva SD, Ferlito A, Takes RP, et al (2011). Advances and applications of oral cancer basic research. Oral Oncol, 47, 783-91. https://doi.org/10.1016/j.oraloncology.2011.07.004
- El-Mofty SK (2014). Histopathologic risk factors in oral and oropharyngeal squamous cell carcinoma variants: an update with special reference to HPV-related carcinomas. Med Oral Patol Oral Cir Bucal, 19, 377-85.
- Fadare O, Reddy H, Wang J, et al (2005). E-Cadherin and beta-Catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases. World J Surg Oncol, 3, 38. https://doi.org/10.1186/1477-7819-3-38
- Gao S, Eiberg H, Krogdahl A, et al (2005). Cytoplasmic expression of E-cadherin and beta-Catenin correlated with LOH and hypermethylation of the APC gene in oral squamous cell carcinomas. J Oral Pathol Med, 34, 116-9. https://doi.org/10.1111/j.1600-0714.2004.00275.x
- Krishna A, Singh RK, Singh S, et al (2014). Demographic risk factors, affected anatomical sites and clinicopathological profile for oral squamous cell carcinoma in a north Indian population. Asian Pac J Cancer Prev, 15, 6755-60. https://doi.org/10.7314/APJCP.2014.15.16.6755
- Krishna Rao SV, Mejia G, Roberts-Thomson K, et al (2013). Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012). Asian Pac J Cancer Prev, 14, 5567-77. https://doi.org/10.7314/APJCP.2013.14.10.5567
- Kuo CH, Lin YW, Chen RS (2015). Lipopeptides extract from bacillus amyloliquefaciens induce human oral squamous cancer cell death. Asian Pac J Cancer Prev, 16, 91-6. https://doi.org/10.7314/APJCP.2015.16.1.91
- Kurtz KA, Hoffman HT, Zimmerman MB, et al (2006). Decreased E-cadherin but not beta-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas. Otolaryngol Head Neck Surg, 134, 142-6. https://doi.org/10.1016/j.otohns.2005.08.026
- Lopes FF, da Costa Miguel MC, Pereira AL, et al (2009). Changes in immunoexpression of E-cadherin and betacatenin in oral squamous cell carcinoma with and without nodal metastasis. Ann Diagn Pathol, 13, 22-9. https://doi.org/10.1016/j.anndiagpath.2008.07.006
- MacDonald BT, Tamai K, He X (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell, 17, 9-26. https://doi.org/10.1016/j.devcel.2009.06.016
- Monteiro LS, Antunes L, Bento MJ, et al (2013). Incidence rates and trends of lip, oral and oro-pharyngeal cancers in Portugal. J Oral Pathol Med, 42, 345-51. https://doi.org/10.1111/jop.12010
- Odajima T, Sasaki Y, Tanaka N, et al (2005). Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Hum Pathol, 36, 234-41. https://doi.org/10.1016/j.humpath.2004.12.009
- Orecchia R, Rampino M, Gribaudo S, et al (1991). Interstitial brachytherapy for carcinomas of the lower lip. results of treatment. Tumori, 77, 336-8.
- Pigneux J, Richaud PM, Lagarde C (1979). The place of interstitial therapy using 192 iridium in the management of carcinoma of the lip. Cancer, 43, 1073-7. https://doi.org/10.1002/1097-0142(197903)43:3<1073::AID-CNCR2820430343>3.0.CO;2-8
- Tombolini V, Bonanni A, Valeriani M, et al (1998). Brachytherapy for squamous cell carcinoma of the lip. the experience of the institute of radiology of the university of Rome "La Sapienza". Tumori, 84, 478-82.
- Yothaisong S, Thanee M, Namwat N, et al (2014). Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/beta-catenin signaling pathways in a cholangiocarcinogenesis model. Asian Pac J Cancer Prev, 15, 10463-8.
- Zaid KW (2014). Immunohistochemical assessment of E-cadherin and beta-catenin in the histological differentiations of oral squamous cell carcinoma. Asian Pac J Cancer Prev, 15, 8847-53. https://doi.org/10.7314/APJCP.2014.15.20.8847
- Zhu DW, Yuan YX, Qiao JK, et al (2015). Enhanced anticancer activity of a protein phosphatase 2A inhibitor on chemotherapy and radiation in head and neck squamous cell carcinoma. Cancer Lett, 356, 773-80. https://doi.org/10.1016/j.canlet.2014.10.024
피인용 문헌
- Protein Expression of Stromelysin-2 in Head and Neck Squamous Cell Carcinomas vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7843